AI-Mind presented at Alzheimer Europe and ISPOR Europe conferences
Dr. Ira Haraldsen from Oslo University Hospital (Norway) presented at Alzheimer Europe conference.
Dr. Signe Daugbjerg from Universita Cattolica Del Sacro Cuore (Italy) presented at ISPOR Europe conference.
At the 31st Alzheimer Europe conference held online from 29 November to 1 December 2021, Dr. Ira Haraldsen from Oslo University Hospital (Norway), representing and leading the EU-funded AI-Mind project, presented a quick-oral presentation entitled “AI-Mind: artificial intelligence as key for dementia prevention for people affected by Mild Cognitive Impairment”. Patients and carers, policymakers, academics, and clinicians were among the audience.
The presentation provided an overview of the AI-Mind project, including its objectives, key facts, consortium, concept, and expected outcomes. The AI-Mind clinical study is a key part of the project and will help develop and validate artificial intelligence (AI)-based tools to predict who is likely to develop dementia. The study will enroll people with mild cognitive impairment in January 2022 in Italy, Spain, Finland and Norway.
The AI-Mind Consortium also had the opportunity to hold a branded virtual booth during the Alzheimer Europe conference, where the AI-Mind communication tools were showcased, such as the website, infographic, factsheet and explanatory video. All the materials give an overview of why and how the AI-Mind innovations will contribute to dementia risk estimation and impact patients’ medical journey.
The AI-Mind project was also represented at the Virtual ISPOR Europe 2021 conference held between 30 November to 3 December under the theme “Emerging Frontiers and Opportunities: Special Populations and Technologies”. Dr. Signe Daugbjerg from Universita Cattolica Del Sacro Cuore (Italy) presented a poster entitled “Assessment Methods of Artificial Intelligence Supported Health Technologies. A Systematic Literature Review and Web-page Search”. In this work, a literature review of studies describing methods or frameworks to assess AI-supported health technologies was performed as well as a web-page search of international agencies to identify important aspects to consider when implementing and assessing AI technologies.